TESTING AND REJECTION OF DELIVERED PRODUCTS Sample Clauses

TESTING AND REJECTION OF DELIVERED PRODUCTS. (a) Dura shall be entitled, at its cost and expense, to test any and all Products delivered to it hereunder to determine whether such Products comply with the Specifications. Dura shall notify Lilly in writing promptly, and in any event not later than thirty (30) days after its receipt thereof, if it rejects any Products delivered to it by reason of the failure of such Products to meet the Specifications. Products not rejected within such thirty (30) day period shall be deemed accepted. Lilly shall use reasonable efforts to replace the rejected Products with Products which meet the Specifications within the shortest possible time and shall deliver such replacement Products, at its sole cost and expense, to Dura. In addition, Lilly shall, at its sole cost and expense, arrange for all such noncomplying Products to be picked up promptly in accordance with all Applicable Laws. Dura shall have no responsibility to Lilly for the purchase prices of nonconforming Products but shall pay Lilly the purchase prices for the replacement Products within 30 days of delivery thereof.
AutoNDA by SimpleDocs
TESTING AND REJECTION OF DELIVERED PRODUCTS. (a) Xxxxxxx shall be entitled, at its sole cost and expense, to test any and all Products delivered to it hereunder to determine whether any such Products are Defective Products. Such testing of the Products shall be conducted in accordance with procedures and requirements to be mutually agreed upon by Xxxxxxx and Hydro Med. Xxxxxxx shall notify Hydro Med in writing promptly, and in any event not later than thirty (30) days after its receipt thereof, if it rejects any Products delivered to it because Xxxxxxx believes that such Products are Defective Products. Products not rejected within such thirty (30) day period by Xxxxxxx shall be deemed accepted by Xxxxxxx. Hydro Med shall use reasonable efforts to replace any Defective Products with Products which are not Defective Products within the shortest possible time and shall deliver such replacement Products to Xxxxxxx. In addition, Hydro Med shall arrange for all such Defective Products to be picked up promptly in accordance with all Applicable Laws.
TESTING AND REJECTION OF DELIVERED PRODUCTS. ViroPharma shall be entitled at its expense, to evaluate Product Manufactured by OSG to determine whether a Defect exists. In the event of a Defect, ViroPharma will notify OSG in writing within [***] ([***]) days after its receipt of Product. Product not rejected within such [***] ([***]) day period will be deemed accepted. In the event a Defect in [***] Indicates material that has been omitted and for which confidential treatment has been requested. All such omitted material has been filed with the Securities and Exchange Commission pursuant to Rule 24b-2 under the Securities Exchange Act of 1934, as amended. the Product could not reasonably be discovered within this [***] ([***]) day period “Latent Defect”, ViroPharma shall have the right to reject such Product within [***] ([***]) days after discovering the Defect. OSG shall reimburse to ViroPharma [***]. OSG shall replace the rejected Product with Product that is not defective within [***] ([***]) days of completion of the investigation of the Defect. OSG will deliver such replacement Product to ViroPharma [***]. If both companies decide that the product cannot be reworked or used, OSG will, [***], arrange for all such Defective Product to be picked up and destroyed in accordance with all Applicable Laws, and shall deliver to ViroPharma a certificate of destruction signed by an authorized representative of OSG. ViroPharma’s actual or deemed acceptance of Product shall not be construed as limiting any remedies given ViroPharma at law or under this Agreement. Notwithstanding the foregoing, ViroPharma shall not have the right to reject Product that is not saleable because of inadequacies or deficiencies in the Specifications.

Related to TESTING AND REJECTION OF DELIVERED PRODUCTS

  • Quality Specifications SANMINA-SCI shall comply with the quality specifications set forth in its Quality Manual, incorporated by reference herein, a copy of which is available from SANMINA-SCI upon request.

  • Manufacturing and Marketing Rights The Company has not granted rights to manufacture, produce, assemble, license, market, or sell its products to any other person and is not bound by any agreement that affects the Company's exclusive right to develop, manufacture, assemble, distribute, market, or sell its products.

  • Product Specifications The Company agrees that all Products sold to Xxxx hereunder shall conform to the respective specifications set forth on Schedule A or to such other specifications as are from time to time agreed upon by the Parties.

  • Labeling and Packaging BTG shall label and package the Bulk Product in accordance with Legal Requirements applicable to pharmaceutical products shipped in bulk for further processing, labeling, or repackaging.

  • Manufacturing and Supply Genentech shall be responsible for manufacturing and supplying Licensed Products for clinical use and commercial sale in the Genentech Field.

  • Quality Agreement Each Party will comply with the terms of the Quality Agreement in the performance of its obligations hereunder including record retention, audits and inspections, change control, adverse events and product recall. The Parties will conduct periodic Product quality reviews in accordance with the terms of the Quality Agreement.

  • Quality Assurance Licensee agrees that all use of the Licensed Subject Matter shall be only upon the Products manufactured by or for Licensee in accordance with quality standards approved by Licensor prior to the commencement of manufacturing of the Products. Licensee shall submit for Licensor's sole and absolute approval the type of cereal, the name of cereal, the packaging design, advertising material, and all other materials to be used in connection with the Products subject to the sole and absolute approval of Licensor which shall not be unreasonably delayed or withheld.

  • Deliverables Upon completion of each Test for each Reviewable Receivable, the Asset Representations Reviewer shall record a finding based on the issues discovered. Findings categories are listed as follows: • Evidence that the applicable Test was satisfied (“Satisfied Test”); • Evidence that the applicable Test was not satisfied (“Unsatisfied Test”); and • Test incomplete as a result of missing or insufficient documentation (“Unsatisfied Test – Missing Required Documents”).

  • Packaging and Labeling 11.1 Company shall provide packaging and labeling specifications that call out clear labeling requirements.

  • Money Market Fund Compliance Testing and Reporting Services Subject to the authorization and direction of the Trust and, in each case where appropriate, the review and comment by the Trust’s independent accountants and legal counsel, and in accordance with procedures that may be established from time to time between the Trust and the Administrator, the Administrator will:

Time is Money Join Law Insider Premium to draft better contracts faster.